To include your compound in the COVID-19 Resource Center, submit it here.

Alnylam proposes $675M follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) proposed on Monday to raise $675 million in a follow-on underwritten by

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE